Navigation Links
LaVoie Group Adds Two New Companies to Its Life Science Client Roster
Date:11/19/2007

SALEM, Mass., Nov. 19 /PRNewswire/ -- LaVoie Group, a life sciences focused, corporate, investor and public relations firm, today announced that it has been selected as agency of record by Agile Therapeutics, of Princeton, NJ, and The GI Company, of Framingham, MA.

Donna LaVoie, President and CEO, commented, "LaVoie Group is engaged in providing strategic communications counsel and tactical execution to these exciting companies as they accelerate interactions with the venture capital, biopharmaceutical and professional medical communities. The addition of these clients underscores the increasingly diverse nature of our life sciences roster."

Ms. LaVoie continued, "Agile Therapeutics is a specialty pharmaceutical company addressing unmet needs in women's healthcare, while The GI Company specializes in developing drugs for gastrointestinal and related diseases. Both are poised to make an impact in their respective therapeutic areas."

About Agile Therapeutics

Agile Therapeutics is a specialty pharmaceutical company focused on the development of innovative women's healthcare products. The company's late- stage products are driven by a market need for a convenient and reliable low- dose contraceptive patch. Agile is capitalizing on its executive team's proven expertise in transdermal technology, drug development, and fertility management to build a pipeline of women's health products through line extensions and/or in-licensing. For more information, visit http://www.agiletherapeutics.com.

About The GI Company

The GI Company is a clinical-stage biotechnology company highly specialized at developing drugs to treat gastrointestinal and related diseases. The company's lead clinical candidate, Intestinal Trefoil Factor (ITF), is being developed for the treatment of oral mucositis, a common, debilitating complication resulting from high-dose chemotherapy and/or radiotherapy. Phase II clinical results are expected to be released in the 1st half of 2008. The GI Company also has pre-clinical development programs in enteritis/proctitis, inflammatory bowel disease, erosive gastroesophageal reflux disease, peptic ulcer disease and gastrointestinal motility disorders, as well as clinical programs in erosive gastritis (NSAID induced), ulcerative colitis and corneal wound healing. For more information, visit http://www.thegicompany.com.

About LaVoie Group

LaVoie Group provides senior level strategic counsel and tactical implementation of public, investor and corporate communications programs designed to properly position, create visibility and drive value for each client. Our clients range from private start-ups to industry leaders in life sciences. For more information, visit http://www.lavoiegroup.com.


'/>"/>
SOURCE LaVoie Group
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
4. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
5. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
6. AMERIGROUP to Acquire Memphis Health Plan
7. Securians Minnesota Life Continues to Climb Group Life Rankings
8. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
9. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
10. Group B Strep: A Threat to Newborns That Doesnt Have to Be
11. Cynosure to Present at the Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Petersburg, Fla. (PRWEB) , ... December 05, 2016 , ... ... concussions have on the growing brains of young athletes. Over the course of three ... the head through unique mouth guards. The mouth guards, equipped with special sensors, will ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
(Date:12/5/2016)... Missouri (PRWEB) , ... December 05, 2016 , ... ... ethnic, gender, and geographic lines. The goal of Castlewood Treatment Centers has always ... treatment accessible to as many people as possible. In that spirit, Castlewood ...
(Date:12/5/2016)... ... ... U.S. Apple Association (USApple) begins the holiday giving season by donating $17,800 to ... Buy an Apple, Help a Student fundraising campaign. , Winning ideas ... their families; solar technology to efficiently process compost; and iPads to enhance student learning. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... portfolio company, today announced it has acquired the assets of Frankfurt, Germany ... a subsidiary of Chiltern International and focuses on clinical trial drug packaging, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 5, 2016  Recently Zymo Research announced an ... known as Horvath,s Clock. Based on this technology, ... service to academic and biopharma scientific researchers to ... other than sperm. The service quantifies ... age versus chronological age following drug treatments and ...
(Date:12/5/2016)... Ill. , Dec. 5, 2016 For ... score on the 2017 Human Rights Campaign Foundation,s ... The CEI is a national benchmarking tool used to ... bisexual, and transgender (LGBT) employee equality. For ... Survey to help companies gauge their equality efforts, culture ...
(Date:12/5/2016)... WOODCLIFF LAKE, N.J. , Dec. 5, 2016 /PRNewswire/ ... on perampanel presented at the 2016 Annual Meeting of ... marketed as FYCOMPA® CIII, is indicated as an adjunctive ... with or without secondarily generalized seizures and primary generalized ... 12 years of age and older. Please see Important ...
Breaking Medicine Technology: